(Q41623707)

5 October 2017

1 reference

title

Inhibition of nitric oxide formation by aminoguanidine: an attempt to prevent insulin-dependent diabetes mellitus (English)

1 reference

5 October 2017

3

Sandler S

1 reference

5 October 2017

Holstad M

1

1 reference

5 October 2017

Jansson L

series ordinal

2

1 reference

5 October 2017

publication date

1 November 1997

1 reference

5 October 2017

1 reference

5 October 2017

volume

29

1 reference

5 October 2017

issue

5

1 reference

5 October 2017

page(s)

697-700

1 reference

Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Selective inhibition of inducible nitric oxide synthase by aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Type I diabetes mellitus. A chronic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Cytokines suppress human islet function irrespective of their effects on nitric oxide generation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Effects of aminoguanidine on rat pancreatic islets in culture and on the pancreatic islet blood flow of anaesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Aminoguanidine-provoked leukocyte adherence to rat mesenteric venules: role of constitutive nitric oxide synthase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Nitric oxide: a physiologic messenger

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

The HLA-IDDM association: implications for etiology and pathogenesis of IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Biochemical and Molecular Actions of Interleukin-1 on Pancreatic β-Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

The blood flow in pancreatico-duodenal grafts in rats: inhibition of nitric oxide synthase preferentially decreases islet blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Effects of aminoguanidine on insulin release from pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Nitric oxide and arginine-evoked insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Interleukin-lβ-Induced Nitric Oxide Production in Isolated Rat Pancreatic Islets Requires Gene Transcription and May Lead to Inhibition of the Krebs Cycle Enzyme Aconitase*

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900012-8

7 January 2021

10.1016/S0306-3623(97)00012-8

Identifiers

DOI

1 reference

5 October 2017

1 reference